Stempeutics receives US patent nod for CLI treatment drug

Drug major Cipla on Wednesday said its joint venture firm Stempeutics Research has received a process patent approval from the US Patent and Trademarks Office (USPTO) for its stem-cell based drug Stempeucel, used in treating critical limb ischemia (CLI).



from Zee News :Zee News - Health http://bit.ly/1AI5cap via Health News Daily